These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21191064)

  • 1. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells.
    Beurel E; Yeh WI; Michalek SM; Harrington LE; Jope RS
    J Immunol; 2011 Feb; 186(3):1391-8. PubMed ID: 21191064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease.
    Staschke KA; Dong S; Saha J; Zhao J; Brooks NA; Hepburn DL; Xia J; Gulen MF; Kang Z; Altuntas CZ; Tuohy VK; Gilmour R; Li X; Na S
    J Immunol; 2009 Jul; 183(1):568-77. PubMed ID: 19542468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
    Beurel E; Kaidanovich-Beilin O; Yeh WI; Song L; Palomo V; Michalek SM; Woodgett JR; Harrington LE; Eldar-Finkelman H; Martinez A; Jope RS
    J Immunol; 2013 May; 190(10):5000-11. PubMed ID: 23606540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 promotes T helper type 17 differentiation by promoting interleukin-9 production.
    Han D; Medina-Rodriguez EM; Lowell JA; Beurel E
    Immunology; 2020 Aug; 160(4):357-365. PubMed ID: 32277469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta promotes Th17 cell development through inhibition of SOCS3.
    Qin H; Wang L; Feng T; Elson CO; Niyongere SA; Lee SJ; Reynolds SL; Weaver CT; Roarty K; Serra R; Benveniste EN; Cong Y
    J Immunol; 2009 Jul; 183(1):97-105. PubMed ID: 19535626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production.
    Wang H; Brown J; Garcia CA; Tang Y; Benakanakere MR; Greenway T; Alard P; Kinane DF; Martin M
    J Immunol; 2011 Jan; 186(2):675-84. PubMed ID: 21160051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dysregulation by the rheumatoid arthritis shared epitope.
    De Almeida DE; Ling S; Pi X; Hartmann-Scruggs AM; Pumpens P; Holoshitz J
    J Immunol; 2010 Aug; 185(3):1927-34. PubMed ID: 20592276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter.
    Hill EV; Ng TH; Burton BR; Oakley CM; Malik K; Wraith DC
    Eur J Immunol; 2015 Apr; 45(4):1103-15. PubMed ID: 25627813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
    Zhang P; Katz J; Michalek SM
    Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.
    Diveu C; McGeachy MJ; Boniface K; Stumhofer JS; Sathe M; Joyce-Shaikh B; Chen Y; Tato CM; McClanahan TK; de Waal Malefyt R; Hunter CA; Cua DJ; Kastelein RA
    J Immunol; 2009 May; 182(9):5748-56. PubMed ID: 19380822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization.
    Ono T; Yanagawa Y; Iwabuchi K; Nonomura K; Onoé K
    Immunology; 2007 Oct; 122(2):189-98. PubMed ID: 17490435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.
    Lee SW; Park HJ; Jeon SH; Lee C; Seong RH; Park SH; Hong S
    PLoS One; 2015; 10(7):e0132329. PubMed ID: 26147219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betaine Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Dendritic Cell-Derived IL-6 Production and Th17 Differentiation.
    Yang C; Lai W; Zhou J; Zheng X; Cai Y; Yang W; Xie S; Gao Y; Du C
    J Immunol; 2018 Feb; 200(4):1316-1324. PubMed ID: 29330324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory properties of copolymer I in Th17 differentiation by altering STAT3 phosphorylation.
    Chen C; Liu X; Wan B; Zhang JZ
    J Immunol; 2009 Jul; 183(1):246-53. PubMed ID: 19542436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
    J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
    Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
    J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine.
    Qin X; Guo BT; Wan B; Fang L; Lu L; Wu L; Zang YQ; Zhang JZ
    J Immunol; 2010 Aug; 185(3):1855-63. PubMed ID: 20622114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.
    Newcomb DC; Zhou W; Moore ML; Goleniewska K; Hershey GK; Kolls JK; Peebles RS
    J Immunol; 2009 May; 182(9):5317-21. PubMed ID: 19380778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
    Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
    J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.